Souders Financial Advisors

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1811240 CINCINNATI, OH

Position in ALNY

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$532,522

-$11,428 QoQ

Shares Held

1,769

+7.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#473

of 780 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Souders Financial Advisors holds $1,759,941 across 2 Biotechnology names. ALNY ranks #2 (30.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,471	$1,227,419
2	ALNY	Alnylam Pharmaceuticals, Inc. This page	1,769	$532,522

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$532,522	1,769	+7.6%	Shares	Sole	2026-08-05
2026-03-31	$543,950	1,644	+16.6%	Shares	Sole	2026-05-04
2025-12-31	$560,686	1,410	-0.9%	Shares	Sole	2026-02-02
2025-09-30	$648,888	1,423	+4.7%	Shares	Sole	2025-11-04
2025-06-30	$443,156	1,359	-24.2%	Shares	Sole	2025-08-06
2025-03-31	$484,145	1,793	-34.6%	Shares	Sole	2025-05-05
2024-12-31	$644,749	2,740	-18.3%	Shares	Sole	2025-02-06
2024-09-30	$922,175	3,353	-4.5%	Shares	Sole	2024-11-05
2024-06-30	$853,416	3,512	+1.0%	Shares	Sole	2024-08-28
2024-03-31	$519,488	3,476	+18.0%	Shares	Sole	2024-05-08
2023-12-31	$564,085	2,947	+9.5%	Shares	Sole	2024-01-24
2023-09-30	$476,753	2,692	+1.5%	Shares	Sole	2023-11-06
2023-06-30	$503,910	2,653	+18.6%	Shares	Sole	2023-08-09
2023-03-31	$447,915	2,236	+2.6%	Shares	Sole	2023-05-09
2022-12-31	$517,839	2,179	+30.7%	Shares	Sole	2023-02-13
2022-09-30	$333,666	1,667	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.